US Stock MarketDetailed Quotes

Whitehawk Therapeutics (WHWK)

Watchlist
  • 4.110
  • -0.120-2.84%
Close Apr 17 15:59 ET
  • 4.058
  • -0.052-1.27%
Post 20:01 ET
193.98MMarket Cap-12.45P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Whitehawk Therapeutics (WHWK) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.62%-97.43M
-14.49%-17.23M
1.97%-15.38M
-478.32%-52.96M
39.63%-11.86M
0.19%-59.55M
-56.09%-15.05M
-31.26%-15.69M
45.36%-9.16M
7.78%-19.65M
Net income from continuing operations
67.66%-20.6M
-27.24%-23.25M
-41.45%-17.75M
-260.80%-52.62M
499.23%73.02M
3.15%-63.69M
-12.32%-18.27M
23.04%-12.55M
18.85%-14.58M
-20.14%-18.29M
Operating gains losses
---87.27M
--0
--177K
--0
---87.44M
----
----
----
----
----
Depreciation and amortization
-59.07%79K
-97.87%1K
-89.36%5K
-67.35%16K
14.00%57K
14.20%193K
6.82%47K
6.82%47K
13.95%49K
31.58%50K
Other non cash items
-83.91%74K
--0
--0
--0
-57.23%74K
-11.37%460K
-33.04%77K
-17.39%95K
0.00%115K
-0.57%173K
Change In working capital
131.90%1.93M
212.91%4.46M
103.34%185K
-222.67%-3.45M
115.42%733K
-77.73%-6.05M
-62.90%1.43M
-419.53%-5.53M
347.14%2.81M
39.35%-4.75M
-Change in receivables
-140.96%-1M
--0
--0
--0
-280.18%-1M
88.55%-415K
178.17%637K
69.62%-620K
-152.25%-987K
114.99%555K
-Change in inventory
-84.77%170K
--0
--0
--0
-65.31%170K
134.18%1.12M
107.10%158K
95.65%630K
-127.93%-162K
125.23%490K
-Change in prepaid assets
-115.42%-434K
-280.29%-375K
-639.11%-965K
-90.43%141K
-19.73%765K
-21.90%2.81M
-79.79%208K
-89.65%179K
-0.87%1.47M
248.44%953K
-Change in payables and accrued expense
140.14%3.92M
689.02%4.67M
116.15%985K
-208.41%-2.71M
114.41%975K
-7,303.79%-9.77M
-87.71%592K
-453.98%-6.1M
148.73%2.5M
-338.08%-6.76M
-Change in other current assets
-184.56%-438K
7.95%163K
44.74%165K
-865.22%-880K
-17.39%114K
0.00%518K
25.83%151K
-7.32%114K
-27.67%115K
18.97%138K
-Change in other current liabilities
6.13%-291K
--0
--0
--0
-130.95%-291K
38.25%-310K
-152.76%-321K
312.00%265K
-1.59%-128K
-1.61%-126K
Cash from discontinued investing activities
Operating cash flow
-63.62%-97.43M
-14.49%-17.23M
1.97%-15.38M
-478.32%-52.96M
39.63%-11.86M
0.19%-59.55M
-56.09%-15.05M
-31.26%-15.69M
45.36%-9.16M
7.78%-19.65M
Investing cash flow
Cash flow from continuing investing activities
-52.82%11.89M
28.27%16.85M
-1,901.91%-91.63M
-707.22%-28.83M
994.25%115.5M
-69.71%25.2M
259.91%13.13M
-59.86%5.09M
-107.06%-3.57M
-35.36%10.56M
Net PPE purchase and sale
66.63%-552K
--0
--0
99.82%-1K
25.44%-551K
58.36%-1.65M
77.21%-186K
82.88%-188K
21.48%-541K
46.02%-739K
Net business purchase and sale
--101.29M
--0
---70K
--0
--101.36M
--0
--0
--0
--0
--0
Net investment purchase and sale
-430.81%-88.84M
26.48%16.85M
-1,836.34%-91.56M
-851.32%-28.83M
30.10%14.69M
-69.19%26.86M
198.30%13.32M
-61.69%5.27M
-105.91%-3.03M
-36.18%11.29M
Cash from discontinued investing activities
Investing cash flow
-52.82%11.89M
28.27%16.85M
-1,901.91%-91.63M
-707.22%-28.83M
994.25%115.5M
-69.71%25.2M
259.91%13.13M
-59.86%5.09M
-107.06%-3.57M
-35.36%10.56M
Financing cash flow
Cash flow from continuing financing activities
72,496.92%94.38M
-52.83%25K
0
-1,077.01%-850K
952,110.00%95.2M
-60.12%130K
-33.75%53K
0
-72.20%87K
-225.00%-10K
Net common stock issuance
--100M
----
----
--0
--100M
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
-48.63%75K
-192,363.46%-99.98M
--100M
-69.15%29K
--21K
-69.96%146K
-54.39%52K
--0
-74.03%94K
--0
Net other financing activities
-35,531.25%-5.7M
--0
--0
-12,457.14%-879K
-48,120.00%-4.82M
90.00%-16K
102.94%1K
--0
---7K
---10K
Cash from discontinued financing activities
Financing cash flow
72,496.92%94.38M
-52.83%25K
--0
-1,077.01%-850K
952,110.00%95.2M
-60.12%130K
-33.75%53K
--0
-72.20%87K
-225.00%-10K
Net cash flow
Beginning cash position
-54.36%28.73M
23.95%37.93M
251.76%144.94M
322.65%227.57M
-54.36%28.73M
61.07%62.95M
-55.57%30.6M
-39.61%41.2M
57.85%53.84M
61.07%62.95M
Current changes in cash
125.82%8.83M
80.56%-363K
-909.29%-107.01M
-553.69%-82.63M
2,283.08%198.84M
-243.36%-34.22M
68.44%-1.87M
-1,753.98%-10.6M
-137.05%-12.64M
-83.15%-9.11M
End cash Position
30.74%37.57M
30.74%37.57M
23.95%37.93M
251.76%144.94M
322.65%227.57M
-54.36%28.73M
-54.36%28.73M
-55.57%30.6M
-39.61%41.2M
57.85%53.84M
Free cash flow
-60.10%-97.99M
-13.09%-17.23M
3.13%-15.38M
-446.07%-52.96M
39.12%-12.42M
3.82%-61.2M
-45.69%-15.24M
-21.66%-15.88M
44.41%-9.7M
10.08%-20.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.62%-97.43M-14.49%-17.23M1.97%-15.38M-478.32%-52.96M39.63%-11.86M0.19%-59.55M-56.09%-15.05M-31.26%-15.69M45.36%-9.16M7.78%-19.65M
Net income from continuing operations 67.66%-20.6M-27.24%-23.25M-41.45%-17.75M-260.80%-52.62M499.23%73.02M3.15%-63.69M-12.32%-18.27M23.04%-12.55M18.85%-14.58M-20.14%-18.29M
Operating gains losses ---87.27M--0--177K--0---87.44M--------------------
Depreciation and amortization -59.07%79K-97.87%1K-89.36%5K-67.35%16K14.00%57K14.20%193K6.82%47K6.82%47K13.95%49K31.58%50K
Other non cash items -83.91%74K--0--0--0-57.23%74K-11.37%460K-33.04%77K-17.39%95K0.00%115K-0.57%173K
Change In working capital 131.90%1.93M212.91%4.46M103.34%185K-222.67%-3.45M115.42%733K-77.73%-6.05M-62.90%1.43M-419.53%-5.53M347.14%2.81M39.35%-4.75M
-Change in receivables -140.96%-1M--0--0--0-280.18%-1M88.55%-415K178.17%637K69.62%-620K-152.25%-987K114.99%555K
-Change in inventory -84.77%170K--0--0--0-65.31%170K134.18%1.12M107.10%158K95.65%630K-127.93%-162K125.23%490K
-Change in prepaid assets -115.42%-434K-280.29%-375K-639.11%-965K-90.43%141K-19.73%765K-21.90%2.81M-79.79%208K-89.65%179K-0.87%1.47M248.44%953K
-Change in payables and accrued expense 140.14%3.92M689.02%4.67M116.15%985K-208.41%-2.71M114.41%975K-7,303.79%-9.77M-87.71%592K-453.98%-6.1M148.73%2.5M-338.08%-6.76M
-Change in other current assets -184.56%-438K7.95%163K44.74%165K-865.22%-880K-17.39%114K0.00%518K25.83%151K-7.32%114K-27.67%115K18.97%138K
-Change in other current liabilities 6.13%-291K--0--0--0-130.95%-291K38.25%-310K-152.76%-321K312.00%265K-1.59%-128K-1.61%-126K
Cash from discontinued investing activities
Operating cash flow -63.62%-97.43M-14.49%-17.23M1.97%-15.38M-478.32%-52.96M39.63%-11.86M0.19%-59.55M-56.09%-15.05M-31.26%-15.69M45.36%-9.16M7.78%-19.65M
Investing cash flow
Cash flow from continuing investing activities -52.82%11.89M28.27%16.85M-1,901.91%-91.63M-707.22%-28.83M994.25%115.5M-69.71%25.2M259.91%13.13M-59.86%5.09M-107.06%-3.57M-35.36%10.56M
Net PPE purchase and sale 66.63%-552K--0--099.82%-1K25.44%-551K58.36%-1.65M77.21%-186K82.88%-188K21.48%-541K46.02%-739K
Net business purchase and sale --101.29M--0---70K--0--101.36M--0--0--0--0--0
Net investment purchase and sale -430.81%-88.84M26.48%16.85M-1,836.34%-91.56M-851.32%-28.83M30.10%14.69M-69.19%26.86M198.30%13.32M-61.69%5.27M-105.91%-3.03M-36.18%11.29M
Cash from discontinued investing activities
Investing cash flow -52.82%11.89M28.27%16.85M-1,901.91%-91.63M-707.22%-28.83M994.25%115.5M-69.71%25.2M259.91%13.13M-59.86%5.09M-107.06%-3.57M-35.36%10.56M
Financing cash flow
Cash flow from continuing financing activities 72,496.92%94.38M-52.83%25K0-1,077.01%-850K952,110.00%95.2M-60.12%130K-33.75%53K0-72.20%87K-225.00%-10K
Net common stock issuance --100M----------0--100M--0----------0--0
Proceeds from stock option exercised by employees -48.63%75K-192,363.46%-99.98M--100M-69.15%29K--21K-69.96%146K-54.39%52K--0-74.03%94K--0
Net other financing activities -35,531.25%-5.7M--0--0-12,457.14%-879K-48,120.00%-4.82M90.00%-16K102.94%1K--0---7K---10K
Cash from discontinued financing activities
Financing cash flow 72,496.92%94.38M-52.83%25K--0-1,077.01%-850K952,110.00%95.2M-60.12%130K-33.75%53K--0-72.20%87K-225.00%-10K
Net cash flow
Beginning cash position -54.36%28.73M23.95%37.93M251.76%144.94M322.65%227.57M-54.36%28.73M61.07%62.95M-55.57%30.6M-39.61%41.2M57.85%53.84M61.07%62.95M
Current changes in cash 125.82%8.83M80.56%-363K-909.29%-107.01M-553.69%-82.63M2,283.08%198.84M-243.36%-34.22M68.44%-1.87M-1,753.98%-10.6M-137.05%-12.64M-83.15%-9.11M
End cash Position 30.74%37.57M30.74%37.57M23.95%37.93M251.76%144.94M322.65%227.57M-54.36%28.73M-54.36%28.73M-55.57%30.6M-39.61%41.2M57.85%53.84M
Free cash flow -60.10%-97.99M-13.09%-17.23M3.13%-15.38M-446.07%-52.96M39.12%-12.42M3.82%-61.2M-45.69%-15.24M-21.66%-15.88M44.41%-9.7M10.08%-20.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -